BMO Capital Maintains Outperform on Chemours, Raises Price Target to $64
Portfolio Pulse from Benzinga Newsdesk
BMO Capital analyst John McNulty maintains an Outperform rating on Chemours (NYSE:CC) and raises the price target from $54 to $64.
June 05, 2023 | 10:57 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BMO Capital maintains an Outperform rating on Chemours and raises the price target from $54 to $64.
BMO Capital's maintained Outperform rating and increased price target for Chemours (NYSE:CC) indicate a positive outlook for the stock. This news is likely to have a positive impact on the stock price in the short term as it reflects the analyst's confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100